Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 6,766 | 7,650 | 7,417 | 4,812 | 5,929 |
| Operating Income | -6,766 | -7,650 | -7,417 | -4,812 | -5,929 |
| Other Income | 225 | 280 | 66 | 6 | -102 |
| Pre-tax Income | -6,541 | -7,370 | -7,351 | -4,806 | -6,031 |
| Income Tax | -4 | -5 | -5 | -4 | -49 |
| Net Income Continuous | -6,537 | -7,365 | -7,346 | -4,802 | -5,982 |
| Net Income | $-6,537 | $-7,365 | $-7,346 | $-4,802 | $-5,982 |
| EPS Basic Total Ops | 12.61 | -0.41 | -0.63 | -13.85 | -16.78 |
| EPS Basic Continuous Ops | 9.70 | -0.41 | -0.69 | -10.82 | -13.65 |
| EPS Diluted Total Ops | 12.61 | -0.41 | -0.63 | -13.85 | -16.78 |
| EPS Diluted Continuous Ops | 9.70 | -0.41 | -0.69 | -10.82 | -13.65 |
| EBITDA(a) | $-6,757 | $-7,639 | $-7,407 | $-4,803 | $-5,916 |